| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 2.26e-06 | 17 | 114 | 4 | GO:0005132 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | DUSP18 PDE6B ACOT9 ABHD2 DCP2 SLFN14 PPP1R8 PTPN4 PLA2G4C PXDNL ENTPD3 PGLS PDE5A NOCT | 2.04e-04 | 807 | 114 | 14 | GO:0016788 |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.05e-04 | 51 | 114 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 3.36e-04 | 24 | 114 | 3 | GO:0120283 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 4.76e-06 | 21 | 113 | 4 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 8.34e-06 | 24 | 113 | 4 | GO:0033139 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.26e-05 | 55 | 113 | 5 | GO:0043330 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 1.58e-05 | 28 | 113 | 4 | GO:0042501 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 2.46e-05 | 63 | 113 | 5 | GO:0043331 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 2.46e-05 | 63 | 113 | 5 | GO:0050691 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 8.14e-05 | 42 | 113 | 4 | GO:0002323 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 8.89e-05 | 3 | 113 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | ERBB3 NTRK1 NBN IFNA2 IFNA4 IFNA5 GSK3B IFNA21 CEMIP THBS1 CSPG4 TPX2 PDE5A MAPK1 | 9.32e-05 | 780 | 113 | 14 | GO:0042327 |
| GeneOntologyBiologicalProcess | B cell activation | 1.10e-04 | 341 | 113 | 9 | GO:0042113 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 1.21e-04 | 201 | 113 | 7 | GO:0030183 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 1.37e-04 | 90 | 113 | 5 | GO:0050688 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | NTRK1 NBN IFNA2 IFNA4 IFNA5 GSK3B IFNA21 CEMIP THBS1 CSPG4 TPX2 PDE5A MAPK1 | 1.68e-04 | 724 | 113 | 13 | GO:0001934 |
| GeneOntologyBiologicalProcess | relaxation of skeletal muscle | 1.77e-04 | 4 | 113 | 2 | GO:0090076 | |
| GeneOntologyBiologicalProcess | dorsal/ventral axon guidance | 1.77e-04 | 4 | 113 | 2 | GO:0033563 | |
| GeneOntologyBiologicalProcess | regulation of negative chemotaxis | 1.77e-04 | 4 | 113 | 2 | GO:0050923 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 2.29e-04 | 22 | 113 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 2.29e-04 | 22 | 113 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 2.94e-04 | 5 | 113 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | ERBB3 NTRK1 NBN IFNA2 IFNA4 IFNA5 GSK3B IFNA21 CEMIP THBS1 CSPG4 TPX2 PDE5A MAPK1 | 3.20e-04 | 879 | 113 | 14 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | ERBB3 NTRK1 NBN IFNA2 IFNA4 IFNA5 GSK3B IFNA21 CEMIP THBS1 CSPG4 TPX2 PDE5A MAPK1 | 3.20e-04 | 879 | 113 | 14 | GO:0010562 |
| Domain | EGF-like_Ca-bd_dom | 5.78e-08 | 124 | 112 | 9 | IPR001881 | |
| Domain | EGF | COMP LAMB1 CRB1 SLIT2 BMP1 THBS1 FBN2 SLIT1 LRP5 HABP2 SORL1 | 1.70e-07 | 235 | 112 | 11 | SM00181 |
| Domain | EGF-like_dom | COMP LAMB1 CRB1 SLIT2 BMP1 THBS1 FBN2 SLIT1 LRP5 HABP2 SORL1 | 3.04e-07 | 249 | 112 | 11 | IPR000742 |
| Domain | EGF-like_CS | COMP LAMB1 CRB1 SLIT2 BMP1 THBS1 FBN2 SLIT1 LRP5 HABP2 SORL1 | 4.86e-07 | 261 | 112 | 11 | IPR013032 |
| Domain | EGF_2 | COMP LAMB1 CRB1 SLIT2 BMP1 THBS1 FBN2 SLIT1 LRP5 HABP2 SORL1 | 5.65e-07 | 265 | 112 | 11 | PS01186 |
| Domain | EGF_CA | 7.09e-07 | 122 | 112 | 8 | SM00179 | |
| Domain | EGF_3 | 1.51e-06 | 235 | 112 | 10 | PS50026 | |
| Domain | EGF_CA | 2.18e-06 | 99 | 112 | 7 | PS01187 | |
| Domain | Interferon | 2.75e-06 | 17 | 112 | 4 | PF00143 | |
| Domain | INTERFERON_A_B_D | 2.75e-06 | 17 | 112 | 4 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 2.75e-06 | 17 | 112 | 4 | IPR000471 | |
| Domain | IFabd | 2.75e-06 | 17 | 112 | 4 | SM00076 | |
| Domain | EGF_1 | 3.15e-06 | 255 | 112 | 10 | PS00022 | |
| Domain | hEGF | 2.25e-05 | 28 | 112 | 4 | PF12661 | |
| Domain | - | 2.29e-05 | 95 | 112 | 6 | 2.60.120.200 | |
| Domain | Laminin_G | 2.52e-05 | 58 | 112 | 5 | IPR001791 | |
| Domain | EGF_Ca-bd_CS | 2.58e-05 | 97 | 112 | 6 | IPR018097 | |
| Domain | Growth_fac_rcpt_ | 4.31e-05 | 156 | 112 | 7 | IPR009030 | |
| Domain | VWFC_1 | 6.22e-05 | 36 | 112 | 4 | PS01208 | |
| Domain | VWFC_2 | 7.73e-05 | 38 | 112 | 4 | PS50184 | |
| Domain | LAM_G_DOMAIN | 7.73e-05 | 38 | 112 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 9.48e-05 | 40 | 112 | 4 | PF02210 | |
| Domain | EGF | 1.12e-04 | 126 | 112 | 6 | PF00008 | |
| Domain | VWF_dom | 1.15e-04 | 42 | 112 | 4 | IPR001007 | |
| Domain | LamG | 1.38e-04 | 44 | 112 | 4 | SM00282 | |
| Domain | CTCK_1 | 1.60e-04 | 18 | 112 | 3 | PS01185 | |
| Domain | Cys-rich_flank_reg_C | 2.08e-04 | 90 | 112 | 5 | IPR000483 | |
| Domain | LRRCT | 2.08e-04 | 90 | 112 | 5 | SM00082 | |
| Domain | - | 2.28e-04 | 50 | 112 | 4 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 2.46e-04 | 51 | 112 | 4 | IPR012351 | |
| Domain | CT | 2.97e-04 | 22 | 112 | 3 | SM00041 | |
| Domain | TSP_3 | 3.52e-04 | 5 | 112 | 2 | PF02412 | |
| Domain | TSP3 | 3.52e-04 | 5 | 112 | 2 | PS51234 | |
| Domain | TSP_CTER | 3.52e-04 | 5 | 112 | 2 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 3.52e-04 | 5 | 112 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 3.52e-04 | 5 | 112 | 2 | IPR028974 | |
| Domain | - | 3.52e-04 | 5 | 112 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 3.52e-04 | 5 | 112 | 2 | IPR008859 | |
| Domain | TSP_C | 3.52e-04 | 5 | 112 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 3.52e-04 | 5 | 112 | 2 | IPR003367 | |
| Domain | ConA-like_dom | 3.54e-04 | 219 | 112 | 7 | IPR013320 | |
| Domain | Cys_knot_C | 4.39e-04 | 25 | 112 | 3 | IPR006207 | |
| Domain | CTCK_2 | 4.39e-04 | 25 | 112 | 3 | PS01225 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.44e-04 | 106 | 112 | 5 | IPR000152 | |
| Domain | WxxW_domain | 5.26e-04 | 6 | 112 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 5.26e-04 | 6 | 112 | 2 | PF13330 | |
| Domain | FHA | 6.17e-04 | 28 | 112 | 3 | SM00240 | |
| Domain | GAF | 7.34e-04 | 7 | 112 | 2 | PF01590 | |
| Domain | L_dom-like | 8.12e-04 | 328 | 112 | 8 | IPR032675 | |
| Domain | FHA_DOMAIN | 8.35e-04 | 31 | 112 | 3 | PS50006 | |
| Domain | FHA | 8.35e-04 | 31 | 112 | 3 | PF00498 | |
| Domain | GAF | 9.75e-04 | 8 | 112 | 2 | IPR003018 | |
| Domain | GAF | 9.75e-04 | 8 | 112 | 2 | SM00065 | |
| Domain | 4_helix_cytokine-like_core | 1.02e-03 | 74 | 112 | 4 | IPR009079 | |
| Domain | - | 1.25e-03 | 9 | 112 | 2 | 3.30.450.40 | |
| Domain | GAF_dom-like | 1.25e-03 | 9 | 112 | 2 | IPR029016 | |
| Domain | - | 1.30e-03 | 36 | 112 | 3 | 2.60.200.20 | |
| Domain | FHA_dom | 1.30e-03 | 36 | 112 | 3 | IPR000253 | |
| Domain | VWC | 1.52e-03 | 38 | 112 | 3 | SM00214 | |
| Domain | - | 1.64e-03 | 39 | 112 | 3 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 1.76e-03 | 40 | 112 | 3 | IPR023415 | |
| Domain | EGF_CA | 1.78e-03 | 86 | 112 | 4 | PF07645 | |
| Domain | Fol_N | 1.89e-03 | 11 | 112 | 2 | IPR003645 | |
| Domain | Laminin_G_1 | 1.89e-03 | 11 | 112 | 2 | PF00054 | |
| Domain | FOLN | 1.89e-03 | 11 | 112 | 2 | SM00274 | |
| Domain | Ldl_recept_a | 2.48e-03 | 45 | 112 | 3 | PF00057 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.64e-03 | 46 | 112 | 3 | IPR011042 | |
| Domain | - | 2.64e-03 | 46 | 112 | 3 | 4.10.400.10 | |
| Domain | OTU | 2.66e-03 | 13 | 112 | 2 | PF02338 | |
| Domain | LRRNT | 2.87e-03 | 98 | 112 | 4 | IPR000372 | |
| Domain | LRRNT | 2.87e-03 | 98 | 112 | 4 | SM00013 | |
| Domain | LDLRA_1 | 2.98e-03 | 48 | 112 | 3 | PS01209 | |
| Domain | ASX_HYDROXYL | 3.09e-03 | 100 | 112 | 4 | PS00010 | |
| Domain | Ldl_recept_b | 3.09e-03 | 14 | 112 | 2 | PF00058 | |
| Domain | LDLRB | 3.09e-03 | 14 | 112 | 2 | PS51120 | |
| Domain | CUB | 3.16e-03 | 49 | 112 | 3 | PF00431 | |
| Domain | LDrepeatLR_classA_rpt | 3.16e-03 | 49 | 112 | 3 | IPR002172 | |
| Domain | LDLa | 3.16e-03 | 49 | 112 | 3 | SM00192 | |
| Domain | LDLRA_2 | 3.16e-03 | 49 | 112 | 3 | PS50068 | |
| Domain | - | 3.23e-03 | 321 | 112 | 7 | 3.80.10.10 | |
| Domain | CUB | 3.35e-03 | 50 | 112 | 3 | SM00042 | |
| Domain | OTU | 3.56e-03 | 15 | 112 | 2 | PS50802 | |
| Domain | LY | 3.56e-03 | 15 | 112 | 2 | SM00135 | |
| Domain | OTU_dom | 3.56e-03 | 15 | 112 | 2 | IPR003323 | |
| Domain | LDLR_classB_rpt | 3.56e-03 | 15 | 112 | 2 | IPR000033 | |
| Domain | LRR_8 | 3.70e-03 | 171 | 112 | 5 | PF13855 | |
| Domain | - | 3.75e-03 | 52 | 112 | 3 | 2.60.120.290 | |
| Domain | SMAD_FHA_domain | 3.75e-03 | 52 | 112 | 3 | IPR008984 | |
| Domain | CUB | 3.95e-03 | 53 | 112 | 3 | PS01180 | |
| Domain | CUB_dom | 4.85e-03 | 57 | 112 | 3 | IPR000859 | |
| Domain | PDEase | 5.70e-03 | 19 | 112 | 2 | IPR023088 | |
| Domain | Leu-rich_rpt | 5.87e-03 | 271 | 112 | 6 | IPR001611 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COMP LAMB1 HIF3A IFNA2 IFNA4 IFNA5 GSK3B IFNA21 THBS1 PIK3CD TBC1D1 MAPK1 | 1.17e-06 | 326 | 91 | 12 | MM15917 |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 2.80e-06 | 35 | 91 | 5 | M6382 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 3.63e-06 | 17 | 91 | 4 | M47564 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 3.73e-06 | 65 | 91 | 6 | M272 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 4.64e-06 | 18 | 91 | 4 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 5.85e-06 | 19 | 91 | 4 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 7.27e-06 | 20 | 91 | 4 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 8.94e-06 | 21 | 91 | 4 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 1.09e-05 | 22 | 91 | 4 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.09e-05 | 22 | 91 | 4 | M47616 | |
| Pathway | WP_PI3KAKT_SIGNALING | COMP NTRK1 LAMB1 IFNA2 IFNA4 IFNA5 GSK3B IFNA21 THBS1 PIK3CD MAPK1 | 1.12e-05 | 339 | 91 | 11 | M39736 |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.31e-05 | 23 | 91 | 4 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 1.31e-05 | 23 | 91 | 4 | M47452 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 1.56e-05 | 24 | 91 | 4 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 1.56e-05 | 24 | 91 | 4 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 1.56e-05 | 24 | 91 | 4 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 2.18e-05 | 26 | 91 | 4 | M982 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 2.88e-05 | 137 | 91 | 7 | M5669 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 3.92e-05 | 30 | 91 | 4 | M936 | |
| Pathway | WP_FOCAL_ADHESION | 4.27e-05 | 199 | 91 | 8 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 4.27e-05 | 199 | 91 | 8 | M7253 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 4.47e-05 | 31 | 91 | 4 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 4.47e-05 | 31 | 91 | 4 | M47964 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 5.02e-05 | 102 | 91 | 6 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 5.30e-05 | 103 | 91 | 6 | M39434 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 5.37e-05 | 151 | 91 | 7 | M39801 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 5.76e-05 | 33 | 91 | 4 | M39870 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 6.50e-05 | 34 | 91 | 4 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 7.30e-05 | 35 | 91 | 4 | M48246 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 9.12e-05 | 37 | 91 | 4 | M39785 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.85e-04 | 82 | 91 | 5 | M1002 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 2.07e-04 | 84 | 91 | 5 | M39839 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 2.34e-04 | 19 | 91 | 3 | MM1571 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 2.44e-04 | 87 | 91 | 5 | MM15915 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.44e-04 | 87 | 91 | 5 | M12467 | |
| Pathway | WP_ERBB_SIGNALING | 3.17e-04 | 92 | 91 | 5 | M39715 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 3.22e-04 | 51 | 91 | 4 | M39721 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 3.47e-04 | 52 | 91 | 4 | M13103 | |
| Pathway | WP_CANCER_PATHWAYS | NTRK1 LAMB1 IFNA2 IFNA4 IFNA5 GSK3B IFNA21 PIK3CD LRP5 PRKCB MAPK1 | 4.10e-04 | 507 | 91 | 11 | M48302 |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 4.31e-04 | 55 | 91 | 4 | M11844 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 4.45e-04 | 99 | 91 | 5 | MM15905 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 5.58e-04 | 104 | 91 | 5 | M39625 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 6.80e-04 | 27 | 91 | 3 | M1718 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 7.37e-04 | 302 | 91 | 8 | M39719 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 7.58e-04 | 28 | 91 | 3 | MM1378 | |
| Pathway | WP_IL17_SIGNALING | 1.13e-03 | 32 | 91 | 3 | M39560 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.14e-03 | 71 | 91 | 4 | M15913 | |
| Pathway | WP_AXON_GUIDANCE | 1.20e-03 | 72 | 91 | 4 | M48335 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.23e-03 | 33 | 91 | 3 | MM1379 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 1.26e-03 | 73 | 91 | 4 | M39837 | |
| Pathway | WP_FOCAL_ADHESION | 1.32e-03 | 187 | 91 | 6 | MM15913 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 1.39e-03 | 75 | 91 | 4 | M5436 | |
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 4.36e-10 | 13 | 114 | 5 | 18726328 | |
| Pubmed | STBD1 FAM161B ZYX PPP1R8 FBN2 ZNF41 TBC1D1 CSPG4 GLUL LRP5 ANKRD28 RNF216 SPRTN VCPIP1 | 9.47e-09 | 591 | 114 | 14 | 15231748 | |
| Pubmed | 2.16e-08 | 26 | 114 | 5 | 9658081 | ||
| Pubmed | 5.31e-08 | 12 | 114 | 4 | 16565497 | ||
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 5.31e-08 | 12 | 114 | 4 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 5.31e-08 | 12 | 114 | 4 | 1886773 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 5.31e-08 | 12 | 114 | 4 | 7684767 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 5.31e-08 | 12 | 114 | 4 | 16611902 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 5.31e-08 | 12 | 114 | 4 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 5.31e-08 | 12 | 114 | 4 | 3758677 | |
| Pubmed | 5.31e-08 | 12 | 114 | 4 | 8245849 | ||
| Pubmed | 5.31e-08 | 12 | 114 | 4 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 5.31e-08 | 12 | 114 | 4 | 8760352 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 5.31e-08 | 12 | 114 | 4 | 7530016 | |
| Pubmed | 5.31e-08 | 12 | 114 | 4 | 9794206 | ||
| Pubmed | 5.31e-08 | 12 | 114 | 4 | 17451966 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 7.65e-08 | 13 | 114 | 4 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 7.65e-08 | 13 | 114 | 4 | 2014240 | |
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 18005734 | ||
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 7.65e-08 | 13 | 114 | 4 | 6094686 | |
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 1655578 | ||
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 2471809 | ||
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 8438572 | ||
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 7.65e-08 | 13 | 114 | 4 | 23255800 | |
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 7523540 | ||
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 19706714 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 7.65e-08 | 13 | 114 | 4 | 2987810 | |
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 19130550 | ||
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 22739040 | ||
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 9181467 | ||
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 18572754 | ||
| Pubmed | Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest. | 1.07e-07 | 14 | 114 | 4 | 8668211 | |
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 1.07e-07 | 14 | 114 | 4 | 7526537 | |
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 19559726 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 15240719 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 16418394 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 18272764 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 11884139 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 19004943 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 1.07e-07 | 14 | 114 | 4 | 7532202 | |
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 1.07e-07 | 14 | 114 | 4 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 1.07e-07 | 14 | 114 | 4 | 17517919 | |
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 14983024 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 25972534 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 7583919 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 2987811 | ||
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 21172865 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 1.07e-07 | 14 | 114 | 4 | 15254193 | |
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 16278001 | ||
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 1.07e-07 | 14 | 114 | 4 | 1381203 | |
| Pubmed | 1.07e-07 | 14 | 114 | 4 | 8345204 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 18723505 | ||
| Pubmed | 1.45e-07 | 15 | 114 | 4 | 8786318 | ||
| Pubmed | 1.45e-07 | 15 | 114 | 4 | 15684736 | ||
| Pubmed | 1.45e-07 | 15 | 114 | 4 | 9520456 | ||
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 1.45e-07 | 15 | 114 | 4 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 1.45e-07 | 15 | 114 | 4 | 18339807 | |
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 1.45e-07 | 15 | 114 | 4 | 8661419 | |
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 1.93e-07 | 16 | 114 | 4 | 22315404 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 1.93e-07 | 16 | 114 | 4 | 7904170 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 1.93e-07 | 16 | 114 | 4 | 18414664 | |
| Pubmed | 2.52e-07 | 17 | 114 | 4 | 22814248 | ||
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 2.52e-07 | 17 | 114 | 4 | 15233997 | |
| Pubmed | 3.23e-07 | 18 | 114 | 4 | 1905933 | ||
| Pubmed | 4.09e-07 | 19 | 114 | 4 | 7511078 | ||
| Pubmed | 4.09e-07 | 19 | 114 | 4 | 7815507 | ||
| Pubmed | 4.09e-07 | 19 | 114 | 4 | 17360657 | ||
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 4.09e-07 | 19 | 114 | 4 | 1708818 | |
| Pubmed | 4.09e-07 | 19 | 114 | 4 | 1385305 | ||
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 5.09e-07 | 20 | 114 | 4 | 11694501 | |
| Pubmed | 5.09e-07 | 20 | 114 | 4 | 8764000 | ||
| Pubmed | 6.28e-07 | 21 | 114 | 4 | 9108403 | ||
| Pubmed | 7.65e-07 | 22 | 114 | 4 | 7913356 | ||
| Pubmed | 7.65e-07 | 22 | 114 | 4 | 23100517 | ||
| Pubmed | 7.65e-07 | 22 | 114 | 4 | 16160188 | ||
| Pubmed | 9.24e-07 | 23 | 114 | 4 | 9225992 | ||
| Pubmed | PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response. | 1.11e-06 | 24 | 114 | 4 | 35037428 | |
| Pubmed | Role of HIV-1 Vpu protein for virus spread and pathogenesis. | 1.31e-06 | 25 | 114 | 4 | 18672082 | |
| Pubmed | 1.31e-06 | 25 | 114 | 4 | 27183626 | ||
| Pubmed | Modulation of HIV-1 transcription by cytokines and chemokines. | 1.31e-06 | 25 | 114 | 4 | 16375755 | |
| Pubmed | The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation. | 1.55e-06 | 26 | 114 | 4 | 38744293 | |
| Pubmed | Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5. | 1.81e-06 | 27 | 114 | 4 | 33165593 | |
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 1.81e-06 | 27 | 114 | 4 | 30936491 | |
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 17581972 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MBTPS1 MIA3 LAMB1 DNAJB14 BMP1 THBS1 FBN2 GANAB NETO2 CSPG4 TPX2 CCT8 LRP5 WDR62 SLC27A3 SORL1 | 1.99e-06 | 1201 | 114 | 16 | 35696571 |
| Pubmed | 2.09e-06 | 63 | 114 | 5 | 12089333 | ||
| Pubmed | 2.11e-06 | 28 | 114 | 4 | 15481145 | ||
| Pubmed | Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. | 2.11e-06 | 28 | 114 | 4 | 17277142 | |
| Pubmed | The structure of eight distinct cloned human leukocyte interferon cDNAs. | 2.84e-06 | 9 | 114 | 3 | 6163083 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | OBSL1 LAMB1 PTPN4 FBN2 GANAB GLUL PGLS CCT8 ANKRD28 MAPK1 ATP2A1 SLC27A3 VCPIP1 SORL1 | 3.88e-06 | 974 | 114 | 14 | 28675297 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIA3 ACOT9 NBN MLXIP PPP1R8 FBN2 GANAB TBC1D1 CCT8 ANKRD28 CPLANE1 WDR62 VCPIP1 | 4.71e-06 | 853 | 114 | 13 | 28718761 |
| Pubmed | 5.55e-06 | 11 | 114 | 3 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 5.55e-06 | 11 | 114 | 3 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 5.55e-06 | 11 | 114 | 3 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 5.55e-06 | 11 | 114 | 3 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 5.55e-06 | 11 | 114 | 3 | 8389790 | |
| Interaction | CFC1 interactions | 7.04e-06 | 126 | 113 | 7 | int:CFC1 | |
| Interaction | PI15 interactions | 7.22e-06 | 83 | 113 | 6 | int:PI15 | |
| Interaction | DNAJB9 interactions | 1.85e-05 | 202 | 113 | 8 | int:DNAJB9 | |
| Interaction | IFNA13 interactions | 2.74e-05 | 11 | 113 | 3 | int:IFNA13 | |
| Interaction | PRG2 interactions | 3.30e-05 | 285 | 113 | 9 | int:PRG2 | |
| Interaction | IFNA2 interactions | 3.64e-05 | 12 | 113 | 3 | int:IFNA2 | |
| Interaction | DCP1A interactions | 4.21e-05 | 166 | 113 | 7 | int:DCP1A | |
| Interaction | INA interactions | 5.47e-05 | 173 | 113 | 7 | int:INA | |
| Cytoband | 9p22 | 4.38e-07 | 25 | 114 | 4 | 9p22 | |
| Cytoband | Xp11.23 | 9.64e-05 | 95 | 114 | 4 | Xp11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 2.69e-04 | 124 | 114 | 4 | chr9p21 | |
| Cytoband | 16q24 | 8.11e-04 | 17 | 114 | 2 | 16q24 | |
| Cytoband | 16p12.1 | 1.77e-03 | 25 | 114 | 2 | 16p12.1 | |
| GeneFamily | Interferons | 8.52e-06 | 32 | 74 | 4 | 598 | |
| Coexpression | NABA_MATRISOME | COMP LAMB1 IFNA2 IFNA4 IFNA5 IFNA21 SLIT2 BMP1 THBS1 FBN2 PXDNL SERPINB12 CSPG4 SLIT1 PLXNA4 VWA3B HABP2 PZP MUC2 | 9.27e-08 | 1026 | 114 | 19 | M5889 |
| Coexpression | NABA_MATRISOME | COMP LAMB1 IFNA2 IFNA4 IFNA5 IFNA21 SLIT2 BMP1 THBS1 FBN2 SERPINB12 CSPG4 SLIT1 PLXNA4 VWA3B HABP2 PZP MUC2 | 3.58e-07 | 1008 | 114 | 18 | MM17056 |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 1.75e-06 | 131 | 114 | 7 | MM1127 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.37e-06 | 196 | 114 | 8 | M3008 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.08e-05 | 191 | 114 | 7 | MM17059 | |
| Coexpression | BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION | 2.22e-05 | 13 | 114 | 3 | M14238 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.48e-05 | 39 | 114 | 4 | M41095 | |
| Coexpression | NABA_CORE_MATRISOME | 2.79e-05 | 275 | 114 | 8 | M5884 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 3.54e-05 | 85 | 114 | 5 | MM684 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.69e-08 | 199 | 114 | 8 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.69e-08 | 199 | 114 | 8 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-08 | 200 | 114 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.51e-07 | 182 | 114 | 7 | dc32f8f6a3b13918eb8e93c018f5823d86344080 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.41e-07 | 187 | 114 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.69e-07 | 193 | 114 | 7 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.42e-07 | 196 | 114 | 7 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.42e-07 | 196 | 114 | 7 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 7.42e-07 | 196 | 114 | 7 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.50e-07 | 200 | 114 | 7 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.50e-07 | 200 | 114 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.50e-07 | 200 | 114 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 8.50e-07 | 200 | 114 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.65e-06 | 140 | 114 | 6 | 72c272f44e5600b3037c1dbf9d3a4669a35588d8 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-06 | 157 | 114 | 6 | 1f21d78a467fe22c5ab75d0917b840c1ac93f32c | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.07e-06 | 170 | 114 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.03e-06 | 180 | 114 | 6 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 8.74e-06 | 187 | 114 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 8.74e-06 | 187 | 114 | 6 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-06 | 189 | 114 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.86e-06 | 191 | 114 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.86e-06 | 191 | 114 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 192 | 114 | 6 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-05 | 192 | 114 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 192 | 114 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.02e-05 | 192 | 114 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.05e-05 | 193 | 114 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 194 | 114 | 6 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 194 | 114 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 194 | 114 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 195 | 114 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.11e-05 | 195 | 114 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.11e-05 | 195 | 114 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.11e-05 | 195 | 114 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 199 | 114 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.25e-05 | 199 | 114 | 6 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 199 | 114 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.25e-05 | 199 | 114 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.28e-05 | 200 | 114 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-05 | 200 | 114 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-05 | 200 | 114 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.28e-05 | 200 | 114 | 6 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 200 | 114 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-05 | 126 | 114 | 5 | 65c7c0e4cfb5ac58d80b4034d42e9f662116e0d3 | |
| ToppCell | Bronchial-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-05 | 126 | 114 | 5 | b6482ef18e6d9e12ba4810ce7845f9f991cb95bc | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-05 | 126 | 114 | 5 | 12f3d0f60db462f2a9799b3a06005bc871670760 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.36e-05 | 143 | 114 | 5 | 10955b54e4a87d035093a2756291ef1d6a14ab63 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | 6d8b5669eee9b0903c9260fea707d186c9d7fefa | |
| ToppCell | Int-URO-Myeloid-tDC|Int-URO / Disease, Lineage and Cell Type | 6.64e-05 | 165 | 114 | 5 | 9803c3db6cdcf925bea7d9c382bf4fd05acf3509 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 165 | 114 | 5 | 02cd87dfa2ca40e13455a4b9308477e82f76289b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.83e-05 | 166 | 114 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 166 | 114 | 5 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 166 | 114 | 5 | 80e164a89d22098cabe4a99a78283ba69ea0561e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.03e-05 | 167 | 114 | 5 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.23e-05 | 168 | 114 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.23e-05 | 168 | 114 | 5 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.86e-05 | 171 | 114 | 5 | 187b396059f8802265f54bad2b4882cebb809419 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-05 | 172 | 114 | 5 | cc1a45a35f78063b2a777ae905f70f894fbcb22f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-05 | 172 | 114 | 5 | 30c57f5ca2326e8d890d9aac8096c64e5b51a24f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.00e-05 | 176 | 114 | 5 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.24e-05 | 177 | 114 | 5 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.49e-05 | 178 | 114 | 5 | 9e1f2596fcea5b79cc50b58d83706bb8605e224f | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 9.49e-05 | 178 | 114 | 5 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 178 | 114 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.49e-05 | 178 | 114 | 5 | aa659bd283c4dfbe292cd8698bbf6b1999ca3314 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.49e-05 | 178 | 114 | 5 | bf1d273802a4f42e52ea1bd2a0cae2039559c093 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.75e-05 | 179 | 114 | 5 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 180 | 114 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 180 | 114 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 181 | 114 | 5 | dff264815a3569f5666d0bbc3867c0496cd78774 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 1.03e-04 | 181 | 114 | 5 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 1.03e-04 | 181 | 114 | 5 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 1.05e-04 | 182 | 114 | 5 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-04 | 182 | 114 | 5 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 182 | 114 | 5 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 182 | 114 | 5 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.08e-04 | 183 | 114 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 183 | 114 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 183 | 114 | 5 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|lymph-node_spleen / Manually curated celltypes from each tissue | 1.11e-04 | 184 | 114 | 5 | f93373fcde5c31f4ffe67ca0f3ea7f4e906dc88b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-04 | 184 | 114 | 5 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.14e-04 | 185 | 114 | 5 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 186 | 114 | 5 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-04 | 187 | 114 | 5 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.20e-04 | 187 | 114 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| Drug | AC1L1JM9 | 3.11e-06 | 304 | 114 | 10 | CID000005103 | |
| Drug | DTIC | 3.30e-06 | 81 | 114 | 6 | CID005281007 | |
| Drug | Yfrkd | 4.22e-06 | 7 | 114 | 3 | CID000129984 | |
| Drug | 1hiv | 6.72e-06 | 8 | 114 | 3 | CID005479205 | |
| Drug | Chebi:36708 | 6.72e-06 | 8 | 114 | 3 | CID011966289 | |
| Drug | imidazoquinoline | 1.19e-05 | 101 | 114 | 6 | CID005351568 | |
| Drug | pipobroman | 1.43e-05 | 10 | 114 | 3 | CID000004842 | |
| Drug | penciclovir | 1.48e-05 | 30 | 114 | 4 | CID000004725 | |
| Drug | AC1L1HZP | 1.74e-05 | 64 | 114 | 5 | CID000004361 | |
| Drug | IC 87114 | 1.96e-05 | 11 | 114 | 3 | ctd:C477872 | |
| Drug | flesinoxan | 1.96e-05 | 11 | 114 | 3 | CID000057347 | |
| Drug | lobucavir | 2.77e-05 | 35 | 114 | 4 | CID000060786 | |
| Drug | R 842 | 3.37e-05 | 13 | 114 | 3 | CID000130714 | |
| Drug | FMAU | 3.47e-05 | 37 | 114 | 4 | CID000072327 | |
| Drug | malvidin | 4.27e-05 | 14 | 114 | 3 | ctd:C065861 | |
| Drug | Lanicemine | 4.27e-05 | 14 | 114 | 3 | CID003038485 | |
| Drug | gunacin | 4.27e-05 | 14 | 114 | 3 | CID000198547 | |
| Drug | tert-butyl hydroperoxide | MBTPS1 LAMB1 NBN ZYX GSK3B CEP170 PPP1R8 BMP1 GANAB KCND1 MTF1 CSPG4 PGLS MAPK1 TOP1MT | 4.45e-05 | 902 | 114 | 15 | CID000006410 |
| Drug | isocycloheximide | TRAF3IP2 ERBB3 LAMB1 DDC IFNA2 IFNA4 IFNA5 GSK3B THBS1 MTF1 SAFB2 PRKCB MAPK1 NOCT SORL1 | 4.62e-05 | 905 | 114 | 15 | CID000002900 |
| Drug | pppA2'-5'A2'-5'A | 5.32e-05 | 15 | 114 | 3 | CID000125229 | |
| Drug | MS10 | 5.32e-05 | 15 | 114 | 3 | CID007926288 | |
| Drug | GF109203X | 5.57e-05 | 341 | 114 | 9 | CID000002396 | |
| Drug | Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 6774_UP | |
| Drug | Isometheptene mucate; Up 200; 8.2uM; MCF7; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 6524_UP | |
| Drug | FTdR | 7.43e-05 | 3 | 114 | 2 | CID000127931 | |
| Drug | 2'-deoxy-3'-thiacytidine | 7.68e-05 | 87 | 114 | 5 | CID000003877 | |
| Drug | cadmium | 7.89e-05 | 443 | 114 | 10 | CID000002514 | |
| Drug | YNK01 | 7.90e-05 | 17 | 114 | 3 | CID000084071 | |
| Drug | AC1L1K7T | ERBB3 NTRK1 IFNA2 IFNA4 IFNA5 PIK3CD SUPV3L1 CSPG4 SAFB2 PRKCB MAPK1 PZP | 7.90e-05 | 632 | 114 | 12 | CID000005376 |
| Drug | C6-ceramide | 8.56e-05 | 89 | 114 | 5 | CID000375405 | |
| Drug | p203 | 9.44e-05 | 18 | 114 | 3 | CID000019228 | |
| Drug | podophyllin | 9.44e-05 | 18 | 114 | 3 | CID011979494 | |
| Drug | Nyco | 9.44e-05 | 18 | 114 | 3 | CID000071618 | |
| Drug | D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 | 1.06e-04 | 49 | 114 | 4 | CID000365716 | |
| Drug | apropovir | 1.06e-04 | 49 | 114 | 4 | CID000064987 | |
| Drug | adefovir dipivoxil | 1.06e-04 | 49 | 114 | 4 | CID000060871 | |
| Disease | Joint Instability | 4.05e-05 | 3 | 109 | 2 | C0022410 | |
| Disease | Joint laxity | 4.05e-05 | 3 | 109 | 2 | C0086437 | |
| Disease | Stomatitis | 8.07e-05 | 4 | 109 | 2 | C0038362 | |
| Disease | Oral Mucositis | 8.07e-05 | 4 | 109 | 2 | C1568868 | |
| Disease | polycystic liver disease (is_implicated_in) | 1.34e-04 | 5 | 109 | 2 | DOID:0050770 (is_implicated_in) | |
| Disease | response to silica exposure, pneumoconiosis | 1.34e-04 | 5 | 109 | 2 | EFO_0005853, MONDO_0015926 | |
| Disease | CEROID LIPOFUSCINOSIS, NEURONAL, 6 | 2.01e-04 | 6 | 109 | 2 | C1866282 | |
| Disease | heart disease (implicated_via_orthology) | 3.76e-04 | 38 | 109 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Retinal Pigment Epithelial Detachment | 4.79e-04 | 9 | 109 | 2 | C0339546 | |
| Disease | psoriasis | 5.42e-04 | 273 | 109 | 6 | EFO_0000676 | |
| Disease | Liver carcinoma | 6.00e-04 | 507 | 109 | 8 | C2239176 | |
| Disease | Retinal Detachment | 7.28e-04 | 11 | 109 | 2 | C0035305 | |
| Disease | Lymphoma, Lymphocytic, Intermediate | 7.28e-04 | 11 | 109 | 2 | C0751958 | |
| Disease | Behavior Disorders | 8.71e-04 | 12 | 109 | 2 | C0004930 | |
| Disease | Mental disorders | 8.71e-04 | 12 | 109 | 2 | C0004936 | |
| Disease | Mental Disorders, Severe | 8.71e-04 | 12 | 109 | 2 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 8.71e-04 | 12 | 109 | 2 | C0376338 | |
| Disease | lymphocyte count | ERBB3 AMN TRIM58 NTRK1 NBN HIF3A DDC ELMO1 PTPN4 ZNF469 PIK3CD TBC1D1 SUPV3L1 PRKCB | 1.00e-03 | 1464 | 109 | 14 | EFO_0004587 |
| Disease | Skin Abnormalities | 1.03e-03 | 13 | 109 | 2 | C0037268 | |
| Disease | smoking status measurement | MBTPS1 ERBB3 SLFN14 ELMO1 SLIT2 PXDNL ZNF804B PLXNA4 NOCT UNC79 SEZ6 SORL1 | 1.21e-03 | 1160 | 109 | 12 | EFO_0006527 |
| Disease | Alzheimer's disease (is_implicated_in) | 1.48e-03 | 132 | 109 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.57e-03 | 16 | 109 | 2 | C0334634 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 1.77e-03 | 17 | 109 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | myocardial infarction (implicated_via_orthology) | 1.89e-03 | 66 | 109 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | breast size | 2.15e-03 | 69 | 109 | 3 | EFO_0004884 | |
| Disease | anorexia nervosa | 2.24e-03 | 70 | 109 | 3 | MONDO_0005351 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.70e-03 | 257 | 109 | 5 | DOID:10652 (is_marker_for) | |
| Disease | systemising measurement | 2.71e-03 | 21 | 109 | 2 | EFO_0010221 | |
| Disease | Unipolar Depression | 2.79e-03 | 259 | 109 | 5 | C0041696 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 3.25e-03 | 23 | 109 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 3.25e-03 | 23 | 109 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 3.25e-03 | 23 | 109 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 3.25e-03 | 23 | 109 | 2 | C0014556 | |
| Disease | Septicemia | 3.54e-03 | 24 | 109 | 2 | C0036690 | |
| Disease | Sepsis | 3.54e-03 | 24 | 109 | 2 | C0243026 | |
| Disease | Severe Sepsis | 3.54e-03 | 24 | 109 | 2 | C1719672 | |
| Disease | Pyemia | 3.54e-03 | 24 | 109 | 2 | C0034189 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEGDDPLDDHTRCFP | 326 | Q13075 | |
| IHFNRFNPDGEEEDV | 1566 | Q5SW79 | |
| LNGEPREFAHEAECF | 536 | P21860 | |
| ENSSREDKHECPFGR | 401 | Q92556 | |
| PDVHEGCAEEFSASD | 186 | Q6UVK1 | |
| GFCDERLVPFDHAES | 76 | O95336 | |
| FDLFEPLAEHCVGDD | 111 | P08910 | |
| PDQADVDHDFVGDAC | 416 | P49747 | |
| DCAAHSLRAVPFEQE | 361 | Q14416 | |
| FDIDTPDDFGRTCLH | 396 | O15084 | |
| FQLHGDEFCPVLDAT | 186 | Q9Y305 | |
| DAERVPCRHDDVFFP | 131 | Q9BXJ7 | |
| CEPDFHDGFLLEVHR | 156 | Q8TAP6 | |
| APHDCAAREVFEETG | 136 | Q8IU60 | |
| CPEFRHLLNGVEFAD | 281 | P20711 | |
| SQPECAYDHLEVFDG | 796 | P13497 | |
| HCFFTEDGPEERNTF | 611 | Q8WUJ3 | |
| EDGPEERNTFDHCLG | 616 | Q8WUJ3 | |
| THFEGIDCEVFEAPE | 881 | O14983 | |
| SDGEQTEPRFELHCS | 1326 | Q96BY7 | |
| VEPTDGCFIPDESFH | 286 | Q9Y4P1 | |
| GHVFDSLCTVDQRPE | 301 | O75355 | |
| QNVEFCDFSRHEPDG | 181 | Q7Z5L2 | |
| CDFSRHEPDGEAFED | 186 | Q7Z5L2 | |
| DQQEEEQGHCPRPFF | 631 | P20742 | |
| ELEAHVEHCDFGPAR | 96 | Q6ZMN7 | |
| HGVPDDSSDFLDFVC | 821 | P29074 | |
| VHEGDDATFRCEVSP | 1371 | O75147 | |
| CDFGLARVADPDHDH | 166 | P28482 | |
| GECQPAAAAEHREAA | 51 | Q5VV17 | |
| EFLEPAANETVRHGC | 331 | P04629 | |
| PHDSLDLNCDSRDFV | 581 | Q9NSA2 | |
| FPERLGFCQHHDDEV | 271 | Q2Q1W2 | |
| RECQGFAPDAELHIF | 261 | Q14703 | |
| PDEFCHSDFEDASQG | 131 | Q68DU8 | |
| SKDGSFREHPAVCDD | 516 | A6NDA9 | |
| FREHPAVCDDGEGHI | 521 | A6NDA9 | |
| RQPFFHTRCEEDNGG | 291 | O75197 | |
| EVSLEEFSAHPCARD | 1206 | O75197 | |
| SCLKDRHDFGFPQEE | 51 | P01568 | |
| DNEEPHGCFSLAERP | 226 | Q96HB5 | |
| SCLMDRHDFGFPQEE | 51 | P01562 | |
| DHQSDLTERPEEFGF | 1106 | Q9HCM2 | |
| DNVPREFGEHFEFDC | 4821 | Q02817 | |
| LTPPRFDHDEGDQCS | 136 | O76074 | |
| VEDVAECPHFSSFAD | 151 | P35913 | |
| SCLKDRHDFGFPQEE | 51 | P01569 | |
| GEEEAECHRQFRAQP | 206 | Q96MY7 | |
| HASECAPVDGFNEEV | 276 | P07942 | |
| CGPEGERDIKEHAFF | 586 | P05771 | |
| PGDTLDAFHCLFETQ | 681 | P59047 | |
| EQGCEHTSRTEDPFI | 396 | Q9HAP2 | |
| HFPLFNIDACGGDIE | 466 | Q9UP65 | |
| RQEQESPCFLAGDHR | 946 | A1KZ92 | |
| GEHNFCRNPDADEKP | 241 | Q14520 | |
| DPSNCLGIRDFAETH | 131 | Q53G59 | |
| AEETNEGRHFPDNLC | 511 | Q9H799 | |
| HCGSHPLDDFDVPFE | 2516 | Q9H799 | |
| FNFHRGCEADITPED | 186 | Q8TBM8 | |
| PLEACAHSFFDELRD | 331 | P49841 | |
| SCLKDRHDFGFPQEE | 51 | P01563 | |
| PGFELTHNNDCLDID | 1961 | P35556 | |
| APGFLGDHCELNTDE | 251 | P82279 | |
| PGFVEESCEHTDQFQ | 161 | Q68D86 | |
| DVEHNNGPDGCALFF | 226 | Q9UK39 | |
| ECEDGDRFPAHHVIV | 271 | Q6QHF9 | |
| HRVCEDFGVIATFDP | 226 | P15104 | |
| DSGPHRAEFCEACQE | 146 | Q5QGT7 | |
| HCAAPFEEQGEAERH | 3171 | Q5T011 | |
| PHATCFNGEDFDRPV | 656 | Q92673 | |
| ERHIPGAAFFDIDQC | 51 | P25325 | |
| RHDGSEPCVDVLFGD | 56 | Q96EL3 | |
| VFGLSPECDQSEEFH | 876 | P0C7P3 | |
| FGRNPDLCDFTIDHQ | 51 | Q12972 | |
| DNCFEIFGENIPVHS | 271 | Q8N103 | |
| EALEDFTGPDCRFVN | 51 | Q5JRA6 | |
| NEEEHNFFLAPGTCV | 256 | O60934 | |
| EEHFCRDNTLEENPG | 326 | Q9BWX1 | |
| EDDDGQCGEHLPFLV | 61 | Q14872 | |
| EVDQGFDDHNLPCDV | 411 | Q14697 | |
| GHSIFDFIHPCDQEE | 126 | Q9Y2N7 | |
| SAEEGDFTCRAQHPL | 311 | O43699 | |
| ENNDHFELDCTGPSI | 481 | Q5VXU9 | |
| ENSSCGLPREDAFHI | 246 | Q8WWX8 | |
| PSFECRFDHLEVRDG | 96 | Q8NC67 | |
| EFPFEELTQCADAHL | 521 | Q9NWF9 | |
| GHSAPVLDVSFNCDE | 451 | Q9H1Z4 | |
| NDICFGAAHADDLFP | 146 | Q8IYB8 | |
| SCLKDRHDFGFPEEE | 51 | P05014 | |
| GPEAARDVCSHFDLN | 161 | O60287 | |
| FDHENTVDAPFCLNA | 201 | Q96P63 | |
| NFSEVFSPVEDHLDC | 221 | Q12765 | |
| VLEDSEDSFCRRHPG | 96 | O43734 | |
| DHEERPAQRDCSFPG | 331 | O43734 | |
| PNCRHSDLEALFQDF | 616 | A0JNW5 | |
| RGDACKDDFDHDSVP | 926 | P07996 | |
| CLSPEDEEHVFDAFD | 51 | Q8N8Y5 | |
| PCSPHLEFEDERQFN | 641 | A4D1E1 | |
| EVFECRPEHDDFFIS | 216 | Q8NI27 | |
| EVCDNSREHVPSGQF | 106 | O95210 | |
| VCDDQGFLRFHDRTG | 531 | Q5K4L6 | |
| VRNGPSDDFLHCAID | 356 | C9JR72 | |
| CADFRLHEAPDNSEG | 451 | O94964 | |
| QEELHCPSEFDDTFS | 156 | Q86TI0 | |
| HPEADGCQHVVEFDF | 351 | Q969P6 | |
| HEFDSLCDPEVNDFR | 126 | O00329 | |
| GFVIHFFEVPRNDTC | 696 | Q53EL9 | |
| HGGVLCDEEEDLFNP | 1401 | O94813 | |
| EDGRKFDFDACNEVP | 351 | Q14151 | |
| EDRLELCVDAAGHFP | 956 | Q96JH7 | |
| TNNDKDREGHGPEFC | 121 | Q9H040 | |
| AQPAAEELGFHRCFQ | 171 | Q96JG9 | |
| GDVEASEAEDHFFNP | 1076 | O43379 | |
| IFFHCERFDQPIGED | 156 | P51814 | |
| IEADDNGCFPLDGHV | 546 | Q15942 | |
| RFHAFAERTECVEFP | 291 | Q502W6 | |
| ESECRGDPVRDFHQV | 1456 | O75093 | |
| FPDSGHFNVDNIRVC | 191 | P50990 | |
| DFLQEPVSVDCGHSF | 21 | Q8NG06 | |
| DREFHELQGDFSVPD | 151 | Q96JC1 | |
| HPGGRTIDFDCEDDE | 781 | Q9P2D8 | |
| EDEHFEFHSRPCPTK | 451 | Q9ULW0 | |
| NSRLCDFFDPIADHI | 76 | Q8NEJ0 |